Simpson E, Robinson P J, Chandler P, Millrain M M, Pircher H P, Brändle D, Tomlinson P, Antoniou J, Mellor A
Clinical Research Centre, Harrow, Middlesex, U.K.
Immunology. 1994 Jan;81(1):132-6.
Participation of transmembrane (TM) and glycosyl-phosphatidylinositol (GPI) anchored H-2Db molecules in antigen presentation and thymic selection events was investigated using transgenic mice. Both GPI-Db and TM-Db can efficiently present H-Y antigen, influenza and lymphocytic choriomeningitis virus (LCMV) peptides to primed cytotoxic, H-2Db-restricted T cells. Transgenic mice expressing GPI-Db, although unable to reject TM-Db skin grafts, nevertheless generate secondary CTL responses which can lyse TM-Db-bearing targets, indicating that GPI-Db mice fail to delete all TM-Db-reactive T cells. Furthermore, double-transgenic mice bearing GPI-Db and a T-cell receptor (TcR) for H-2Db+LCMV do not positively select receptor positive, CD8+CD4- T cells. This paradoxical behaviour of GPI-Db molecules suggests that the structural requirements for antigen presentation and thymic selection by class I molecules are different and may explain why GPI-linked class I molecules, such as Qa-2, do not appear to function as restriction elements in vivo.
利用转基因小鼠研究了跨膜(TM)和糖基磷脂酰肌醇(GPI)锚定的H-2Db分子在抗原呈递和胸腺选择事件中的参与情况。GPI-Db和TM-Db都能有效地将H-Y抗原、流感病毒和淋巴细胞性脉络丛脑膜炎病毒(LCMV)肽呈递给致敏的细胞毒性、H-2Db限制性T细胞。表达GPI-Db的转基因小鼠虽然无法排斥TM-Db皮肤移植,但仍能产生可裂解携带TM-Db的靶标的二次CTL反应,这表明GPI-Db小鼠未能清除所有对TM-Db有反应的T细胞。此外,携带GPI-Db和针对H-2Db+LCMV的T细胞受体(TcR)的双转基因小鼠不会阳性选择受体阳性、CD8+CD4-T细胞。GPI-Db分子的这种矛盾行为表明,I类分子进行抗原呈递和胸腺选择的结构要求不同,这可能解释了为什么GPI连接的I类分子,如Qa-2,在体内似乎不发挥限制元件的作用。